Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 28;108(26):10662-7.
doi: 10.1073/pnas.1100994108. Epub 2011 Jun 13.

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

Tiziana Schioppa  1 , Robert Moore, Richard G Thompson, Elizabeth C Rosser, Hagen Kulbe, Sergei Nedospasov, Claudia Mauri, Lisa M Coussens, Frances R Balkwill
Affiliations

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

Tiziana Schioppa et al. Proc Natl Acad Sci U S A. .

Abstract

The inflammatory cytokine TNF-α has been recognized as a critical tumor promoter, but the effector cells that mediate its action have not been fully characterized. Because B cells regulate squamous and prostate carcinogenesis, and Tnf(-/-) mice harbor B-cell defects, we investigated the hypothesis that B cells are important effector cells for TNF-α-mediated promotion of cancer development. Using an adoptive transfer strategy and the 7,12-dimethylbenz[α]anthracene/terephthalic acid (DMBA/TPA) two-stage model of skin carcinogenesis, we found that both B cells and TNF-α are critical for the development of DMBA/TPA-induced papilloma. Transfer of B cells from DMBA/TPA-treated wild-type mice to Tnf(-/-) mice rescued papilloma development to a wild-type level, a result not observed when B cells from Tnf(-/-) mice were transferred to Rag2(-/-) mice or when TNF-α was eliminated selectively in B cells. Resistance to papilloma development in Tnf(-/-) mice was associated with increased IFN-γ and CD8(+) T cells in skin and a significant reduction in IL-10-producing B regulatory cells alongside an increase in IFN-γ-producing CD8(+) T cells in the spleen. These data indicate that during DMBA/TPA-induced squamous carcinogenesis TNF-α mediates tumor-promoting activity via regulatory B cells that repress antitumor immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
B cells are involved in DMBA/TPA squamous carcinogenesis. (A) Rag2−/− mice are resistant to DMBA/TPA. ●, C57/Bl6 wild-type mice (n = 24); ■, C57/Bl6 Rag2−/− mice (n = 23); P < 0.0001. This graph shows combined data from two independent experiments. (B) Mice deficient for B cells (Jh mice) are partially resistant to DMBA/TPA skin carcinogenesis. ●, BALB/c wild-type mice (n = 12); ▼, BALB/c Jh mice (n = 12); P < 0.05. (C) Wild-type B cells partially rescue the resistance to carcinogenesis of Rag2−/− mice. ●, wild-type mice (n = 24); ■, Rag2−/− mice (n = 16); ▲, mice with Rag2−/− plus wild-type B cells (n = 21). Wild-type mice versus Rag2−/− mice, P < 0.001; mice with Rag2−/− plus wild-type B cells versus Rag2−/− mice, P < 0.05; mice with Rag2−/− plus wild-type B cells versus wild-type mice = no significant difference. This graph shows combined data from two independent experiments. (D) Wild-type B cells partially rescue the Tnf−/−–resistant phenotype. ●, C57/Bl6 wild-type mice (n = 36); □, C57/Bl6 Tnf−/− mice (n = 2); ▽, C57/Bl6 mice with Tnf−/− plus wild-type B cells (n = 36). P < 0.05. Wild-type mice versus Tnf−/− mice, P < 0.001; mice with Tnf −/− plus wild-type B cells versus Tnf−/− mice, P < 0.05; mice with Tnf−/− plus wild-type B cells versus wild-type mice = no significant difference. This graph shows combined data from three independent experiments. (E) Tnf−/− B cells are not able to rescue the resistant phenotype of Rag2−/− mice. ●, C57/Bl6 wild-type mice (n = 12); ♢, mice with Rag2−/− plus Tnf−/−B cells (n = 11); ■, C57/Bl6 Rag2−/− mice (n = 10); Wild-type mice versus Rag2−/− mice, P < 0.001; mice with Rag2−/− plus Tnf−/− B cells versus wild-type mice, P < 0.001; mice with Rag2−/− plus Tnf−/− B cells versus Rag2−/− mice = no significant difference. (F) CD19-Cre/Tnff/f mice are partially resistant to DMBA/TPA. ●, C57/Bl6 wild-type mice (n = 12); △, C57/Bl6 CD19Cre/Tnff/f mice (n = 12); difference between the groups, P < 0.002. Error bars indicate SE.
Fig. 2.
Fig. 2.
Characterization of the inflammatory status of wild-type and Tnf−/− skin. (A) CD8+ cells are more numerous in Tnf−/− mice than in wild-type mice (Left, wild-type, n = 4; Tnf−/−, n = 4) and are reduced after transfer of wild-type B cells (Right, Tnf−/− n = 3; Tnf−/− plus wild-type B cells, n = 3). *P < 0.05. (B) F4/80+ cells are reduced in Tnf−/− mice compared with wild-type mice (*P < 0.05) (Left, wild-type, n = 4; Tnf−/−, n = 4) and are higher after transfer of wild-type B cells (Right, Tnf−/−, n = 3; Tnf−/− plus wild-type B cells, n = 3). (C) CCL5 mRNA expression. Results are from pooled mRNA from several mice for each group: wild-type and Tnf−/−, n = 4, Tnf−/−, n = 3; and Tnf−/− plus wild-type B cells, n = 3. *P < 0.05, **P < 0.001. (D) IFN-γ mRNA expression. The results are from pooled mRNA from several mice for each group: wild-type and Tnf−/−, n = 4; Tnf−/−, n = 3; and Tnf−/− plus wild-type B cells, n = 3. *P < 0.05. Error bars indicate SE.
Fig. 3.
Fig. 3.
Study of the activation of wild-type and Tnf−/− B cells. (A) C1q/IgG immune complexes in serum of wild-type mice (n = 4), Tnf−/− mice (n = 4), and in mice with Tnf−/− and wild-type B cells (n = 3). Immune complexes are reduced in Tnf−/− mice and are slightly increased after transfer of wild-type B cells but only at the 7-wk time point. *P < 0.05; **P < 0.001). (B) IL-10 production by lymphocytes from wild-type (n = 6) and Tnf−/− (n = 6) inguinal lymph nodes. Mice were treated with DMBA and then TPA for 4 wk. Lymphocytes were kept in culture for 24 h, and cytokine expression was measured by electrochemiluminescence. *P < 0.05. (C) IL-10 and IL-12 total production by wild-type (n = 6) and Tnf−/− (n = 6) B cells after 48 h incubation with LPS (10 μg/mL) and goat F(ab)2 anti-mouse IgM (10 μg/mL). *P < 0.05. Error bars indicate SE.
Fig. 4.
Fig. 4.
Characterization of B-cell subpopulations in wild-type and Tnf−/− mice. (A) B cells (106) from untreated and DMBA/TPA-treated (5 wk) spleens of wild-type and Tnf−/− mice (n = 6) positive for IL-10. *P < 0.05. (B) IL-10 production by B cells from untreated and DMBA/TPA-treated (5 wk) spleens of wild-type and Tnf−/− mice (n = 6) after 24 and 48 h in culture. *P < 0.05; **P < 0.001. ND, not detectable. (C) Percentage (Left) and absolute numbers (Right) of CD19+veCD21hi cells from untreated and DMBA/TPA-treated (5 wk) spleens of wild-type and Tnf−/− mice (n = 6). *P < 0.05. (D) Absolute numbers of CD3+ T cells expressing IFN-γ from untreated and DMBA/TPA-treated (5 wk) spleens of wild-type and Tnf−/− mice (n = 6). *P < 0.05. (E) Absolute numbers of CD3+ T cells expressing IFN-γ from untreated and DMBA/TPA-treated (5 wk) inguinal lymph nodes of wild-type and Tnf−/− mice (n = 6). *P < 0.05. (F) IL-10 production by B cells from untreated spleens of wild-type mice (n = 6) after 6 h in culture with medium only (Control), LPS (10 μg/mL), or LPS (10 μg/mL) plus anti–TNF-α (10 μg/mL). *P < 0.05. Error bars indicate SE.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moore R, et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999;5:828–831. - PubMed
    1. Suganuma M, et al. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 1999;59:4516–4518. - PubMed
    1. Pikarsky E, et al. NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature. 2004;431:461–466. - PubMed
    1. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 2005;121:977–990. - PubMed
    1. Kulbe H, et al. The inflammatory cytokine TNF-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007;67:585–592. - PMC - PubMed

MeSH terms

Substances